These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1215179)

  • 1. [Chronic nephropathy in saturnism. Comparative elimination of lead by classic chelating agents and peritoneal dialysis].
    Mirouze J; Mion C; Mathieu-Daude P; Monnier L; Selam JL
    Nouv Presse Med; 1975 May; 4(22):1642-4. PubMed ID: 1215179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Terzo fuoco", lead poisoning and chronic renal failure].
    Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
    G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate.
    Sánchez-Fructuoso AI; Blanco J; Cano M; Ortega L; Arroyo M; Fernández C; Prats D; Barrientos A
    Am J Kidney Dis; 2002 Jul; 40(1):59-67. PubMed ID: 12087562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lead poisoning: a "forgotten" cause of renal disease.
    Benjelloun M; Tarrass F; Hachim K; Medkouri G; Benghanem MG; Ramdani B
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):83-6. PubMed ID: 17237897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and treatment of occupational lead nephropathy.
    Wedeen RP; Malik DK; Batuman V
    Arch Intern Med; 1979 Jan; 139(1):53-7. PubMed ID: 760684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead and the kidney: nephropathy, hypertension, and gout.
    Perazella MA
    Conn Med; 1996 Sep; 60(9):521-6. PubMed ID: 8908777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination of chelating and dialytic treatment during a course of lead poisoning with serious hemolytic anemia and acute renal insufficiency].
    Alessio L; Imbasciati E; Ghezzi I
    Med Lav; 1976; 67(2):170-5. PubMed ID: 828706
    [No Abstract]   [Full Text] [Related]  

  • 8. Lead mobilization study and the clearance of intravenous CaNa2EDTA in a patient with end-stage renal failure on hemodialysis.
    Roberts DM; Singer RF
    J Clin Pharmacol; 2012 Jan; 52(1):110-3. PubMed ID: 21415282
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-level environmental exposure to lead and progressive chronic kidney diseases.
    Lin JL; Lin-Tan DT; Li YJ; Chen KH; Huang YL
    Am J Med; 2006 Aug; 119(8):707.e1-9. PubMed ID: 16887418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic and lead induced free radical generation and their reversibility following chelation.
    Flora SJ; Flora G; Saxena G; Mishra M
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):26-47. PubMed ID: 17519110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytosis secondary to chronic lead poisoning.
    Al Momen A
    Platelets; 2010; 21(4):297-9. PubMed ID: 20196630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
    Lin-Tan DT; Lin JL; Yen TH; Chen KH; Huang YL
    Nephrol Dial Transplant; 2007 Oct; 22(10):2924-31. PubMed ID: 17556414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum intoxication in a child: treatment with intraperitoneal desferrioxamine.
    Warady BA; Ford DM; Gaston CE; Sedman AB; Huffer WE; Lum GM
    Pediatrics; 1986 Oct; 78(4):651-5. PubMed ID: 3763276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc supplementation of chelation therapy in saturnism. Preliminary study.
    Bădulici S; Chirilă M
    Rom J Intern Med; 1992; 30(3):211-5. PubMed ID: 1475600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of chronic lead poisoning in CAPD patients.
    Kessler M; Durand PY; Hestin D; Gamberoni J; Chanliau J
    Adv Perit Dial; 1993; 9():143-6. PubMed ID: 8105909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deaths associated with hypocalcemia from chelation therapy--Texas, Pennsylvania, and Oregon, 2003-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(8):204-7. PubMed ID: 16511441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of extreme acute lead intoxication.
    Mikler J; Banovcin P; Jesenak M; Hamzikova J; Statelova D
    Toxicol Ind Health; 2009 Mar; 25(2):137-40. PubMed ID: 19458136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute lead poisoning during the perinatal period. A case of encephalopathy in a six week old child treated by peritoneal dialysis].
    Besson-Leaud M; Lavaud J; Buneaux F; Gendrel D; Frejaville JP; Nordmann Y
    Ann Pediatr (Paris); 1977 May; 24(5):373-82. PubMed ID: 16211980
    [No Abstract]   [Full Text] [Related]  

  • 19. [Case of lead nephropathy due to chronic occupational lead exposure].
    Ogata A; Sueta S; Tagawa M
    Nihon Jinzo Gakkai Shi; 2011; 53(2):207-11. PubMed ID: 21516708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.